中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
合肥物质科学研究院 [2]
金属研究所 [1]
长春应用化学研究所 [1]
采集方式
OAI收割 [4]
内容类型
期刊论文 [4]
发表日期
2015 [1]
2013 [2]
2011 [1]
学科主题
筛选
浏览/检索结果:
共4条,第1-4条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
microRNA-218 promotes gemcitabine sensitivity in human pancreatic cancer cells by regulating HMGB1 expression
期刊论文
OAI收割
CHINESE JOURNAL OF CANCER RESEARCH, 2015, 卷号: 27, 期号: 3, 页码: 267-278
作者:
Liu Zhe
;
Du Ruixia
;
Long Jin
;
Guo Kejian
;
Ge Chunlin
  |  
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2021/02/26
GROUP BOX 1
PLUS GEMCITABINE
OVARIAN-CANCER
ADENOCARCINOMA
THERAPY
RESISTANCE
DOCETAXEL
AUTOPHAGY
TARGET
CHEMOTHERAPY
Pancreatic cancer
microRNA-218 (miR-218)
gemcitabine (GEM)
apoptosis
high mobility group box 1 (HMGB1)
A small-molecule induces apoptosis and suppresses metastasis in pancreatic cancer cells
期刊论文
OAI收割
european journal of pharmaceutical sciences, 2013, 卷号: 48, 期号: 41734, 页码: 658-667
Li D
;
Liu ZJ
;
Zhao WJ
;
Zheng XL
;
Wang J
;
Wang EK
收藏
  |  
浏览/下载:28/0
  |  
提交时间:2014/04/16
GROWTH-FACTOR RECEPTOR
PHASE-III TRIAL
CYTOCHROME-C
ANTITUMOR-ACTIVITY
PLUS GEMCITABINE
TYROSINE KINASE
BCL-2 FAMILY
RAS
RESISTANCE
THERAPY
Methylenetetrahydrofolate reductase C677T polymorphism predicts response and time to progression to gemcitabine-based chemotherapy for advanced non-small cell lung cancer in a Chinese Han population
期刊论文
OAI收割
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2013, 卷号: 14
-
  |  
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2020/10/26
COLORECTAL-CANCER
GENE POLYMORPHISMS
CLINICAL-RESPONSE
PLUS CARBOPLATIN
REPAIR GENES
SURVIVAL
ERCC1
ASSOCIATION
PLATINUM
FOLATE
Non-small cell lung cancer
Single nucleotide polymorphism
Methylenetetrahydrofolate reductase
Gemcitabine
Excision repair cross-complementation group 1
Long-term outcomes of gemcitabine and cisplatin in patients with recurrent or metastatic esophageal squamous cell carcinoma: a phase II trial
期刊论文
OAI收割
CHINESE MEDICAL JOURNAL, 2011, 卷号: 124
-
  |  
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2020/10/26
PLUS CISPLATIN
ONCOLOGY-GROUP
CANCER
CHEMOTHERAPY
DOCETAXEL
chemotherapy
gemcitabine
cisplatin
esophageal cancer